The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 16, 2019
Filed:
Aug. 10, 2016
Applicant:
Viiv Healthcare Uk (No. 5) Limited, Brentford, Middlesex, GB;
Inventors:
Kyle J. Eastman, Wallingford, CT (US);
John F. Kadow, Wallingford, CT (US);
B. Narasimhulu Naidu, Wallingford, CT (US);
Kyle E. Parcella, Wallingford, CT (US);
Manoj Patel, Wallingford, CT (US);
Prasanna Sivaprakasam, Wallingford, CT (US);
Yong Tu, Wallingford, CT (US);
Assignee:
ViiV HEALTHCARE UK (NO. 5) LIMITED, Brentford, Middlesex, GB;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/444 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 401/04 (2006.01); C07D 487/04 (2006.01); A61P 31/18 (2006.01); A61K 31/5365 (2006.01);
U.S. Cl.
CPC ...
C07D 401/04 (2013.01); A61P 31/18 (2018.01); C07D 401/14 (2013.01); C07D 405/14 (2013.01); C07D 487/04 (2013.01); A61K 31/5365 (2013.01); A61K 2300/00 (2013.01);
Abstract
Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV.